Shamil' A. Gitinov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shamil' A. Gitinov has a total of 173 co-authors. Here are the top co-authors by number of shared publications:
- Dmitry Yurievich Ovsyannikov
RUDN University (Patrice Émery Lumumba People’s Friendship University of Russia), Moscow, Russia
13 shared publications - Maxim A. Karpenko
Peoples’ Friendship University of Russia named after Patrice Lumumba
7 shared publications - Mariya A. Zhestkova
Peoples’ Friendship University of Russia named after Patrice Lumumba
6 shared publications - Elena Efimovna Petryaykina
Pirogov Russian National Research Medical University
5 shared publications - Evgeniia V. Boitsova
Saint Petersburg State Pediatric Medical University
5 shared publications - Valerii V. Gorev
Morozovskaya Children’s Clinical Hospital
5 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 3,p. 214-220
Idiopathic pulmonary hemosiderosis in children: results of a multicenter study
Background. Idiopathic pulmonary hemosiderosis (IPH) is a rare interstitial lung disease associated with recurrent diffuse alveolar hemorrhage, anemia, and the risk of pulmonary fibrosis. Aim. To describe the clinical and laboratory, computed tomographic, diagnostic, therapeutic characteristics and outcomes of children with IPH. Materials and methods. This ambispective descriptive multicenter study included 11 patients with disease onset before 18 years of age and pulmonary hemorrhage/hemosiderosis documented by bronchoscopy with bronchoalveolar lavage, cytological and/or morphological examination, after exclusion of alternative causes. Clinical history, laboratory and instrumental findings, treatment, and outcomes were evaluated. Results. The cohort included 5 boys and 6 girls. The median age at IPH onset was 6.0 [3.7; 8.6] years, the median age at diagnosis was 8.0 [4.9; 9.7] years, the median diagnostic delay was 4.9 [1.8; 22.8] months, and the median minimum hemoglobin level was 52 [38.5; 98.5] g/L (data available for 10 patients). Anemia was documented in all patients, and hemoptysis in 6/11 (55%). Signs of diffuse lung involvement on chest CT were present in all patients; ground-glass opacities and consolidation were the most common findings. Six patients required ICU care, 3 required mechanical ventilation, and 8 received red blood cell transfusions. All patients received systemic glucocorticoids; azathioprine was used in 5, rituximab in 4, and cyclophosphamide in 1 patient. Three patients died. Conclusion. IPH debuts anemia in children. The absence of hemoptysis does not exclude diffuse alveolar hemorrhage. Early computed tomography of the chest organs, bronchoscopy with bronchoalveolar lavage, the search for siderophages and the exclusion of secondary causes are the key stages of diagnosis. In severe and recurrent cases, multidisciplinary management and steroid-sparing immunosuppressive therapy are required.
- 14 October 2026
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 3,p. 214-220
Open AccessIdiopathic pulmonary hemosiderosis in children: results of a multicenter study
Background. Idiopathic pulmonary hemosiderosis (IPH) is a rare interstitial lung disease associated with recurrent diffuse alveolar hemorrhage, anemia, and the risk of pulmonary fibrosis. Aim. To describe the clinical and laboratory, computed tomographic, diagnostic, therapeutic characteristics and outcomes of children with IPH. Materials and methods. This ambispective descriptive multicenter study included 11 patients with disease onset before 18 years of age and pulmonary hemorrhage/hemosiderosis documented by bronchoscopy with bronchoalveolar lavage, cytological and/or morphological examination, after exclusion of alternative causes. Clinical history, laboratory and instrumental findings, treatment, and outcomes were evaluated. Results. The cohort included 5 boys and 6 girls. The median age at IPH onset was 6.0 [3.7; 8.6] years, the median age at diagnosis was 8.0 [4.9; 9.7] years, the median diagnostic delay was 4.9 [1.8; 22.8] months, and the median minimum hemoglobin level was 52 [38.5; 98.5] g/L (data available for 10 patients). Anemia was documented in all patients, and hemoptysis in 6/11 (55%). Signs of diffuse lung involvement on chest CT were present in all patients; ground-glass opacities and consolidation were the most common findings. Six patients required ICU care, 3 required mechanical ventilation, and 8 received red blood cell transfusions. All patients received systemic glucocorticoids; azathioprine was used in 5, rituximab in 4, and cyclophosphamide in 1 patient. Three patients died. Conclusion. IPH debuts anemia in children. The absence of hemoptysis does not exclude diffuse alveolar hemorrhage. Early computed tomography of the chest organs, bronchoscopy with bronchoalveolar lavage, the search for siderophages and the exclusion of secondary causes are the key stages of diagnosis. In severe and recurrent cases, multidisciplinary management and steroid-sparing immunosuppressive therapy are required.
- Open Access
- 27 November 2025
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 24 (4) , 54-60
Post-infectious bronchiolitis obliterans in children
Post-infectious bronchiolitis obliterans (PIBO) is a chronic obstructive lung disease that develops in children following lower respiratory tract infections (LRTI). The pathogenesis is based on impaired reparative processes in the bronchiolar epithelium, productive-sclerotic inflammation, and the formation of peribronchiolar fibrosis, accompanied by chronic neutrophilic-lymphocytic inflammation and cytokine imbalance. The clinical presentation of PIBO is characterized by chronic cough, expiratory dyspnea, hypoxemia, and prolonged bronchial obstruction. The diagnosis is established based on a history of severe LRTI, persistent clinical signs of airway obstruction, and characteristic findings on chest computed tomography, including mosaic attenuation and air-trapping phenomena. Despite the use of various pharmacological strategies, including systemic and inhaled corticosteroids, macrolides, and leukotriene receptor antagonists, a standardized therapy protocol for PIBO has not yet been established. The disease course is variable: most patients demonstrate a reduction in respiratory symptoms and improvement in functional parameters with age, whereas others may experience slow disease progression. Computed tomography features of small airway involvement may persist or vary over time.
- 27 November 2025
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 24 (4) , 54-60
Open AccessPost-infectious bronchiolitis obliterans in children
Post-infectious bronchiolitis obliterans (PIBO) is a chronic obstructive lung disease that develops in children following lower respiratory tract infections (LRTI). The pathogenesis is based on impaired reparative processes in the bronchiolar epithelium, productive-sclerotic inflammation, and the formation of peribronchiolar fibrosis, accompanied by chronic neutrophilic-lymphocytic inflammation and cytokine imbalance. The clinical presentation of PIBO is characterized by chronic cough, expiratory dyspnea, hypoxemia, and prolonged bronchial obstruction. The diagnosis is established based on a history of severe LRTI, persistent clinical signs of airway obstruction, and characteristic findings on chest computed tomography, including mosaic attenuation and air-trapping phenomena. Despite the use of various pharmacological strategies, including systemic and inhaled corticosteroids, macrolides, and leukotriene receptor antagonists, a standardized therapy protocol for PIBO has not yet been established. The disease course is variable: most patients demonstrate a reduction in respiratory symptoms and improvement in functional parameters with age, whereas others may experience slow disease progression. Computed tomography features of small airway involvement may persist or vary over time.
- 9 September 2025
- Published by Farmarus Print Media in Russian Journal of Allergy
- Vol. 22 (3) , 335-349
Bronchiolitis obliterans is a fatal complication of Stevens–Johnson syndrome/toxic epidermal necrolysis in an adolescent with epilepsy treated with lamotrigine and nonsteroidal anti-inflammatory drugs: clinical and morphological comparisons
Bronchiolitis obliterans is a rare severe complication of Stevens–Johnson syndrome and toxic epidermal necrolysis. The article presents an observation of a fatal histologically confirmed bronchiolitis obliterans in a 16-year-old patient developed as a delayed complication of Stevens–Johnson syndrome after the use of lamotrigine and nonsteroidal anti-inflammatory drugs. The diagnosis of bronchiolitis obliterans was established based on the development of severe bronchoobstructive syndrome, confirmed by a study of the external respiratory function, chronic respiratory failure 2 months after Stevens–Johnson syndrome, characteristic computed tomography signs (foci of mosaic perfusion, bronchiectasis). Bronchiolitis obliterans therapy, in addition to commonly used drugs, included the janus kinase inhibitor tofacitinib. To discuss clinical observation, a systematic review of the world literature over 45 years was conducted. 43 cases of post-Stevens–Johnson syndrome/toxic epidermal necrolysis were selected from 187 publications with an analysis of the etiology, timing of onset, spirometric and radiological signs, features of therapy and course. According to the analysis, the main triggers of Stevens–Johnson syndrome/toxic epidermal necrolysis were antibiotics (50 %) and nonsteroidal anti-inflammatory drugs (40 %), infection caused by Mycoplasma pneumoniae (12 %), and less often anticonvulsants. The average age of children with bronchiolitis obliterans was 7 years, and the average age of adults was 28 years. In 50 % of cases, the manifestation of bronchiolitis obliterans occurred 1–3 months after the start of Stevens–Johnson syndrome/toxic epidermal necrolysis. Most patients (35 %) had severe bronchoobstructive syndrome, and characteristic computed tomography signs included mosaic perfusion (75 %) and bronchiectasis (49 %). Systemic (77 %) and inhaled (35 %) glucocorticosteroids, bronchodilators (63 %), and macrolide antibiotics (26 %) formed the basis of bronchiolitis obliterans therapy. Mortality in the analyzed cases reached 30 %, complete recovery was observed in only 33 %, and 35 % of patients retained persistent bronchoobstructive syndrome.
- 9 September 2025
- Published by Farmarus Print Media in Russian Journal of Allergy
- Vol. 22 (3) , 335-349
Bronchiolitis obliterans is a fatal complication of Stevens–Johnson syndrome/toxic epidermal necrolysis in an adolescent with epilepsy treated with lamotrigine and nonsteroidal anti-inflammatory drugs: clinical and morphological comparisons
Bronchiolitis obliterans is a rare severe complication of Stevens–Johnson syndrome and toxic epidermal necrolysis. The article presents an observation of a fatal histologically confirmed bronchiolitis obliterans in a 16-year-old patient developed as a delayed complication of Stevens–Johnson syndrome after the use of lamotrigine and nonsteroidal anti-inflammatory drugs. The diagnosis of bronchiolitis obliterans was established based on the development of severe bronchoobstructive syndrome, confirmed by a study of the external respiratory function, chronic respiratory failure 2 months after Stevens–Johnson syndrome, characteristic computed tomography signs (foci of mosaic perfusion, bronchiectasis). Bronchiolitis obliterans therapy, in addition to commonly used drugs, included the janus kinase inhibitor tofacitinib. To discuss clinical observation, a systematic review of the world literature over 45 years was conducted. 43 cases of post-Stevens–Johnson syndrome/toxic epidermal necrolysis were selected from 187 publications with an analysis of the etiology, timing of onset, spirometric and radiological signs, features of therapy and course. According to the analysis, the main triggers of Stevens–Johnson syndrome/toxic epidermal necrolysis were antibiotics (50 %) and nonsteroidal anti-inflammatory drugs (40 %), infection caused by Mycoplasma pneumoniae (12 %), and less often anticonvulsants. The average age of children with bronchiolitis obliterans was 7 years, and the average age of adults was 28 years. In 50 % of cases, the manifestation of bronchiolitis obliterans occurred 1–3 months after the start of Stevens–Johnson syndrome/toxic epidermal necrolysis. Most patients (35 %) had severe bronchoobstructive syndrome, and characteristic computed tomography signs included mosaic perfusion (75 %) and bronchiectasis (49 %). Systemic (77 %) and inhaled (35 %) glucocorticosteroids, bronchodilators (63 %), and macrolide antibiotics (26 %) formed the basis of bronchiolitis obliterans therapy. Mortality in the analyzed cases reached 30 %, complete recovery was observed in only 33 %, and 35 % of patients retained persistent bronchoobstructive syndrome.
- Open Access
- 1 January 2025
- Published by Geotar-Media Publishing Group in Neonatology: News, Opinions, Training
- Vol. 13 (1)
“Riddles” of acute bronchiolitis
- 1 January 2025
- Published by Geotar-Media Publishing Group in Neonatology: News, Opinions, Training
- Vol. 13 (1)
Open Access“Riddles” of acute bronchiolitis
- Open Access
- 15 September 2024
- Published by LLC Global Media Technology in Archives of Pediatrics and Pediatric Surgery
- Vol. 2 (2) , 65-68
Clinical and laboratory-instrumental features of pneumonia caused by Mycoplasma pneumoniae in childhood
Mycoplasma pneumoniae is the most common causative agent of bacterial pneumonia among school-age children. The study analyzed the clinical cases of 460 children hospitalized with radiologically confirmed pneumonia in the period from 2022 to 2023. Pneumonia caused by Mycoplasma pneumoniae was detected in 198 patients. The diagnosis was confirmed by ELISA diagnostics and PCR diagnostics. Clinically, pneumonia of this pathogen proceeded without complications, did not require treatment in intensive care and intensive care. Mycoplasma pneumoniae is most often observed among preschool and school-age children. In this regard, an examination for Mycoplasma pneumoniae should be carried out in preschool and school-age children to identify the pathogen and timely prescribe antibacterial therapy.
- 15 September 2024
- Published by LLC Global Media Technology in Archives of Pediatrics and Pediatric Surgery
- Vol. 2 (2) , 65-68
Open AccessClinical and laboratory-instrumental features of pneumonia caused by Mycoplasma pneumoniae in childhood
Mycoplasma pneumoniae is the most common causative agent of bacterial pneumonia among school-age children. The study analyzed the clinical cases of 460 children hospitalized with radiologically confirmed pneumonia in the period from 2022 to 2023. Pneumonia caused by Mycoplasma pneumoniae was detected in 198 patients. The diagnosis was confirmed by ELISA diagnostics and PCR diagnostics. Clinically, pneumonia of this pathogen proceeded without complications, did not require treatment in intensive care and intensive care. Mycoplasma pneumoniae is most often observed among preschool and school-age children. In this regard, an examination for Mycoplasma pneumoniae should be carried out in preschool and school-age children to identify the pathogen and timely prescribe antibacterial therapy.
- Open Access
- 24 June 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (2) , 45-51
Extrapulmonary manifestations of Mycoplasma pneumoniae infection in children
Mycoplasma pneumoniae (M. pn.), which is a well-known pathogen to cause atypical pneumonia, in 25% of cases can lead to a wide range of extra-pulmonary symptoms, reflecting damage to almost any organ or organ system (skin and mucous membranes, nervous, cardiovascular, gastrointestinal, urinary system etc.). Aspecific syndrome Mycoplasma pneumoniae-induced rash and mucositis (MIRM) has been identified recently. Among the CNS manifestations associated with M. pn., acute postinfectious cerebellar ataxia is worth mentioning. In this article we present clinical cases of a 14-year-old boy and a 6-year-old girl with extrapulmonary manifestations of M. pn. infection. This article considers etiological, pathogenetic and clinical features of mycoplasma infection in children with an emphasis on extra-respiratory manifestations.
- 24 June 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (2) , 45-51
Open AccessExtrapulmonary manifestations of Mycoplasma pneumoniae infection in children
Mycoplasma pneumoniae (M. pn.), which is a well-known pathogen to cause atypical pneumonia, in 25% of cases can lead to a wide range of extra-pulmonary symptoms, reflecting damage to almost any organ or organ system (skin and mucous membranes, nervous, cardiovascular, gastrointestinal, urinary system etc.). Aspecific syndrome Mycoplasma pneumoniae-induced rash and mucositis (MIRM) has been identified recently. Among the CNS manifestations associated with M. pn., acute postinfectious cerebellar ataxia is worth mentioning. In this article we present clinical cases of a 14-year-old boy and a 6-year-old girl with extrapulmonary manifestations of M. pn. infection. This article considers etiological, pathogenetic and clinical features of mycoplasma infection in children with an emphasis on extra-respiratory manifestations.
- Open Access
- 27 April 2024
- Published by National Medical Research Center for Childrens Health in L.O. Badalyan Neurological Journal
- Vol. 5 (1) , 14-28
NKX2-1-conditioned disorder — «brain–lung–thyroid» syndrome: results of a multicenter study
Introduction. Brain–lung–thyroid syndrome (BLTS, choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction) is an autosomal dominant disorder associated with mutations of the NKX2-1 gene. A triad of symptoms from three organs (brain, lungs, thyroid gland) is manifested in 50% of patients, in other cases there is an incomplete phenotype of the disease. The most common manifestations are neurological. The aim of the study was to provide genetic, clinical, laboratory, and instrumental characteristics in BLTS patients with a clinical and morphological assessment of the phenotype. Materials and methods. Ten children from 9 families with identified mutations in the NKX2-1 gene were observed. Methods used: genealogical, Sanger sequencing, clinical and morphological assessment of the phenotype, examination of thyroid hormone levels, CT, MRI of the brain, CT of the chest, lung biopsy. Results. The article presents the results of molecular genetic analysis, family history, age of manifestation and diagnosis. 9 out of 10 children had damage to the central nervous system, thyroid gland, lungs, and one child had a combination of neurological pathology and hypothyroidism. Neurological pathology was represented by benign hereditary chorea (2 children), delayed motor development (8), muscular hypotension (7), ataxia (5), choreoathetosis (1), clonuses (1), seizures (1), hyperkinesis (3); respiratory — respiratory distress syndrome (RDS) of newborns (6), chronic respiratory failure (5), interstitial lung disease (6), bronchial asthma (1), chronic pneumonitis of infants (1), bronchiectasis (1). There are presented changes in computed tomograms of the lungs and during preforming CT, MRI of the brain. Typical developmental microanomalia included a protruding forehead, a wide tip of the nose, elongated narrow palpebral fissure, deep-set eyes, hypertelorism of the eyes, large rotated low-lying auricles, conical fingers. Conclusion. A combination of congenital hypothyroidism, neonatal RDS, heart disease, neurological disorders (hypotension, ataxia, delayed motor development, chorea), craniofacial dysmorphia is the basis for a molecular genetic examination to exclude BLTS.
- 27 April 2024
- Published by National Medical Research Center for Childrens Health in L.O. Badalyan Neurological Journal
- Vol. 5 (1) , 14-28
Open AccessNKX2-1-conditioned disorder — «brain–lung–thyroid» syndrome: results of a multicenter study
Introduction. Brain–lung–thyroid syndrome (BLTS, choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction) is an autosomal dominant disorder associated with mutations of the NKX2-1 gene. A triad of symptoms from three organs (brain, lungs, thyroid gland) is manifested in 50% of patients, in other cases there is an incomplete phenotype of the disease. The most common manifestations are neurological. The aim of the study was to provide genetic, clinical, laboratory, and instrumental characteristics in BLTS patients with a clinical and morphological assessment of the phenotype. Materials and methods. Ten children from 9 families with identified mutations in the NKX2-1 gene were observed. Methods used: genealogical, Sanger sequencing, clinical and morphological assessment of the phenotype, examination of thyroid hormone levels, CT, MRI of the brain, CT of the chest, lung biopsy. Results. The article presents the results of molecular genetic analysis, family history, age of manifestation and diagnosis. 9 out of 10 children had damage to the central nervous system, thyroid gland, lungs, and one child had a combination of neurological pathology and hypothyroidism. Neurological pathology was represented by benign hereditary chorea (2 children), delayed motor development (8), muscular hypotension (7), ataxia (5), choreoathetosis (1), clonuses (1), seizures (1), hyperkinesis (3); respiratory — respiratory distress syndrome (RDS) of newborns (6), chronic respiratory failure (5), interstitial lung disease (6), bronchial asthma (1), chronic pneumonitis of infants (1), bronchiectasis (1). There are presented changes in computed tomograms of the lungs and during preforming CT, MRI of the brain. Typical developmental microanomalia included a protruding forehead, a wide tip of the nose, elongated narrow palpebral fissure, deep-set eyes, hypertelorism of the eyes, large rotated low-lying auricles, conical fingers. Conclusion. A combination of congenital hypothyroidism, neonatal RDS, heart disease, neurological disorders (hypotension, ataxia, delayed motor development, chorea), craniofacial dysmorphia is the basis for a molecular genetic examination to exclude BLTS.
- 13 October 2023
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 102 (5)
INTERSTITIAL LUNG DISEASES IN CHILDREN: MODERN CLASSIFICATION, DIAGNOSTIC ALGORITHM, COMMON THERAPEUTIC APPROACHES
Authors, based on bibliographical research and their own data, provide up-to-date information on interstitial lung diseases (ILD) in children. The classification of ILD in children that is used in the registry of pediatric patients with ILD in the European Union (2022) with a critical analysis is given, and the need for its practical use is substantiated. The algorithm for diagnosing childhood ILD is described in detail starting with the diagnostic criteria for childhood ILD syndrome and possible complications. The algorithm includes step-by-step, sequential steps to diagnose these rare diseases. Taking into account the latest advances in genetics and molecular biology, the main proteins and their encoding genes associated with ILD, types of inheritance and phenotypes are listed as well. Indications and findings during lung biopsy, general approaches to the treatment of ILD in children, including oxygen therapy, drug therapy and other therapy, taking into account the existing consensus of experts, are characterized.
- 13 October 2023
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 102 (5)
INTERSTITIAL LUNG DISEASES IN CHILDREN: MODERN CLASSIFICATION, DIAGNOSTIC ALGORITHM, COMMON THERAPEUTIC APPROACHES
Authors, based on bibliographical research and their own data, provide up-to-date information on interstitial lung diseases (ILD) in children. The classification of ILD in children that is used in the registry of pediatric patients with ILD in the European Union (2022) with a critical analysis is given, and the need for its practical use is substantiated. The algorithm for diagnosing childhood ILD is described in detail starting with the diagnostic criteria for childhood ILD syndrome and possible complications. The algorithm includes step-by-step, sequential steps to diagnose these rare diseases. Taking into account the latest advances in genetics and molecular biology, the main proteins and their encoding genes associated with ILD, types of inheritance and phenotypes are listed as well. Indications and findings during lung biopsy, general approaches to the treatment of ILD in children, including oxygen therapy, drug therapy and other therapy, taking into account the existing consensus of experts, are characterized.
- 21 April 2023
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 102 (2)
PROTRACTED BACTERIAL BRONCHITIS IN CHILDREN: ETIOLOGY, CLINICAL OPTIONS, X-RAY SEMIOTICS, COMORBIDITY
Cough in childhood is one of the most common reasons for and symptoms when contacting a pediatric physician. Chronic (lasting over four weeks) wet/productive cough is of particular diagnostic difficulty when it is caused by protracted bacterial bronchitis (PBB). The purpose of this research was to study the etiology, clinical options, X-ray semiotics and comorbid diseases in children with PBB. Materials and methods used: clinical observation and analysis of case histories of 76 children aged starting 4.5 months up to 16 years old with PBB were carried out from Mar. 2017 to Jun. 2022. Research methods: microbiological, radiography and computed tomography (CT) of the chest, bronchoscopy, allergy diagnostics, spirometry. The design of the study was as follows: multicentre, non-comparative, open-label, non-randomized, ambispective pilot study. Results: PBB is more common in boys (57%) aged 3 to 7 y/o (59%) and is rare in infancy (7%). The majority of patients met the clinical definition of PBB (86%) and responded to 2 weeks of antibiotic therapy with amoxicillin/clavulanate (78%). The microbiological diagnosis of PBB was confirmed in 14% of children based on bronchoscopy with microbiological examination of bronchoalveolar lavage (BAL) fluid or sputum examination. The most common pathogens encountered in BAL, sputum and discharge from the nasopharynx, oropharynx are as follows: S. aureus, M. catarrhalis, H. influenzae and S. pneumoniae. The chest X-ray showed bronchitis changes; the chest CT, which was performed in 10 patients, had showed thickening of the bronchial walls. Bronchial dilatation was found in 3 children, bronchiectasis was found in a single patient. Bronchial asthma was comorbid with PBB, occurred in 22% of PBB cases. Conclusion: it is necessary for a pediatric physician to keep PBB in mind as one of the reasons for chronic wet/productive cough in children in order to correctly and timely diagnose the disease and prescribe its adequate treatment.
- 21 April 2023
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 102 (2)
PROTRACTED BACTERIAL BRONCHITIS IN CHILDREN: ETIOLOGY, CLINICAL OPTIONS, X-RAY SEMIOTICS, COMORBIDITY
Cough in childhood is one of the most common reasons for and symptoms when contacting a pediatric physician. Chronic (lasting over four weeks) wet/productive cough is of particular diagnostic difficulty when it is caused by protracted bacterial bronchitis (PBB). The purpose of this research was to study the etiology, clinical options, X-ray semiotics and comorbid diseases in children with PBB. Materials and methods used: clinical observation and analysis of case histories of 76 children aged starting 4.5 months up to 16 years old with PBB were carried out from Mar. 2017 to Jun. 2022. Research methods: microbiological, radiography and computed tomography (CT) of the chest, bronchoscopy, allergy diagnostics, spirometry. The design of the study was as follows: multicentre, non-comparative, open-label, non-randomized, ambispective pilot study. Results: PBB is more common in boys (57%) aged 3 to 7 y/o (59%) and is rare in infancy (7%). The majority of patients met the clinical definition of PBB (86%) and responded to 2 weeks of antibiotic therapy with amoxicillin/clavulanate (78%). The microbiological diagnosis of PBB was confirmed in 14% of children based on bronchoscopy with microbiological examination of bronchoalveolar lavage (BAL) fluid or sputum examination. The most common pathogens encountered in BAL, sputum and discharge from the nasopharynx, oropharynx are as follows: S. aureus, M. catarrhalis, H. influenzae and S. pneumoniae. The chest X-ray showed bronchitis changes; the chest CT, which was performed in 10 patients, had showed thickening of the bronchial walls. Bronchial dilatation was found in 3 children, bronchiectasis was found in a single patient. Bronchial asthma was comorbid with PBB, occurred in 22% of PBB cases. Conclusion: it is necessary for a pediatric physician to keep PBB in mind as one of the reasons for chronic wet/productive cough in children in order to correctly and timely diagnose the disease and prescribe its adequate treatment.